BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 29555830)

  • 1. The Most N-Terminal Region of THSD7A Is the Predominant Target for Autoimmunity in THSD7A-Associated Membranous Nephropathy.
    Seifert L; Hoxha E; Eichhoff AM; Zahner G; Dehde S; Reinhard L; Koch-Nolte F; Stahl RAK; Tomas NM
    J Am Soc Nephrol; 2018 May; 29(5):1536-1548. PubMed ID: 29555830
    [No Abstract]   [Full Text] [Related]  

  • 2. A Heterologous Model of Thrombospondin Type 1 Domain-Containing 7A-Associated Membranous Nephropathy.
    Tomas NM; Meyer-Schwesinger C; von Spiegel H; Kotb AM; Zahner G; Hoxha E; Helmchen U; Endlich N; Koch-Nolte F; Stahl RAK
    J Am Soc Nephrol; 2017 Nov; 28(11):3262-3277. PubMed ID: 28814510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy.
    Tomas NM; Hoxha E; Reinicke AT; Fester L; Helmchen U; Gerth J; Bachmann F; Budde K; Koch-Nolte F; Zahner G; Rune G; Lambeau G; Meyer-Schwesinger C; Stahl RA
    J Clin Invest; 2016 Jul; 126(7):2519-32. PubMed ID: 27214550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantigens PLA2R and THSD7A in membranous nephropathy share a common epitope motif in the N-terminal domain.
    Fresquet M; Rhoden SJ; Jowitt TA; McKenzie EA; Roberts I; Lennon R; Brenchley PE
    J Autoimmun; 2020 Jan; 106():102308. PubMed ID: 31395435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Antibodies against Thrombospondin Type-I Domain-Containing 7A in Chinese Patients with Idiopathic Membranous Nephropathy.
    Wang J; Cui Z; Lu J; Probst C; Zhang YM; Wang X; Qu Z; Wang F; Meng LQ; Cheng XY; Liu G; Debiec H; Ronco P; Zhao MH
    Clin J Am Soc Nephrol; 2017 Oct; 12(10):1642-1651. PubMed ID: 28801527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.
    Tomas NM; Beck LH; Meyer-Schwesinger C; Seitz-Polski B; Ma H; Zahner G; Dolla G; Hoxha E; Helmchen U; Dabert-Gay AS; Debayle D; Merchant M; Klein J; Salant DJ; Stahl RAK; Lambeau G
    N Engl J Med; 2014 Dec; 371(24):2277-2287. PubMed ID: 25394321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombospondin Type 1 Domain-Containing 7A Localizes to the Slit Diaphragm and Stabilizes Membrane Dynamics of Fully Differentiated Podocytes.
    Herwig J; Skuza S; Sachs W; Sachs M; Failla AV; Rune G; Meyer TN; Fester L; Meyer-Schwesinger C
    J Am Soc Nephrol; 2019 May; 30(5):824-839. PubMed ID: 30971456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Indirect Immunofluorescence Method Facilitates Detection of Thrombospondin Type 1 Domain-Containing 7A-Specific Antibodies in Membranous Nephropathy.
    Hoxha E; Beck LH; Wiech T; Tomas NM; Probst C; Mindorf S; Meyer-Schwesinger C; Zahner G; Stahl PR; Schöpper R; Panzer U; Harendza S; Helmchen U; Salant DJ; Stahl RA
    J Am Soc Nephrol; 2017 Feb; 28(2):520-531. PubMed ID: 27436855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy.
    Zaghrini C; Seitz-Polski B; Justino J; Dolla G; Payré C; Jourde-Chiche N; Van de Logt AE; Booth C; Rigby E; Lonnbro-Widgren J; Nystrom J; Mariat C; Cui Z; Wetzels JFM; Ghiggeri G; Beck LH; Ronco P; Debiec H; Lambeau G
    Kidney Int; 2019 Mar; 95(3):666-679. PubMed ID: 30784662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Membranous Nephropathy in Patients With THSD7A Antibodies Using Immunoadsorption.
    Weinmann-Menke J; Holtz S; Sollinger D; Dörken M; Boedecker S; Schamberger B; Pfister F; Amann K; Lutz J
    Am J Kidney Dis; 2019 Dec; 74(6):849-852. PubMed ID: 31451329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of THSD7A-antibodies not binding to glomerular THSD7A in a patient with diabetes mellitus but no membranous nephropathy.
    Reinhard L; Thomas C; Machalitza M; Lattwein E; Weiss LS; Vitu J; Wiech T; Stahl RAK; Hoxha E
    Sci Rep; 2021 Aug; 11(1):16188. PubMed ID: 34376704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen-Specific IgG Subclasses in Primary and Malignancy-Associated Membranous Nephropathy.
    von Haxthausen F; Reinhard L; Pinnschmidt HO; Rink M; Soave A; Hoxha E; Stahl RAK
    Front Immunol; 2018; 9():3035. PubMed ID: 30619370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Histological Features of Phospholipase A2 Receptor-Associated and Thrombospondin Type-I Domain-containing 7A-Associated Idiopathic Membranous Nephropathy: A Single Center Retrospective Study from China.
    Zhang D; Zou J; Zhang C; Zhang W; Lin F; Jiang G
    Med Sci Monit; 2018 Jul; 24():5076-5083. PubMed ID: 30032157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human anti-thrombospondin type 1 domain-containing 7A antibodies induce membranous nephropathy through activation of lectin complement pathway.
    Wang Z; Wen L; Dou Y; Zhao Z
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29769410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-Autoantibody Signature and Clinical Outcome in Membranous Nephropathy.
    Ghiggeri GM; Seitz-Polski B; Justino J; Zaghrini C; Payré C; Brglez V; Dolla G; Sinico A; Scolari F; Vaglio A; Prunotto M; Candiano G; Radice A; Bruschi M; Lambeau G;
    Clin J Am Soc Nephrol; 2020 Dec; 15(12):1762-1776. PubMed ID: 33257410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular classification of membranous nephropathy.
    Pozdzik A; Touzani F; Brochériou I; Corazza F
    Curr Opin Nephrol Hypertens; 2019 Jul; 28(4):336-344. PubMed ID: 31045661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological characteristics of thrombospondin type 1 domain-containing 7A-associated membranous nephropathy.
    Hara S; Tsuji T; Fukasawa Y; Hisano S; Morito S; Hyodo T; Goto S; Nishi S; Yoshimoto A; Itoh T
    Virchows Arch; 2019 Jun; 474(6):735-743. PubMed ID: 30868298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Insight into the Role of PLA2R and THSD7A in Membranous Nephropathy.
    Zhang P; Huang W; Zheng Q; Tang J; Dong Z; Jiang Y; Liu Y; Liu W
    J Immunol Res; 2021; 2021():8163298. PubMed ID: 34337081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEGF-A Links Angiolymphoid Hyperplasia With Eosinophilia (ALHE) to THSD7A Membranous Nephropathy: A Report of 2 Cases.
    Matsumoto A; Matsui I; Namba T; Sakaguchi Y; Mizuno H; Shirayama Y; Shimada K; Hashimoto N; Doi Y; Yamaguchi S; Kubota K; Oka T; Mori D; Akiyama S; Hamano T; Mizui M; Takabatake Y; Kaneko T; Isaka Y
    Am J Kidney Dis; 2019 Jun; 73(6):880-885. PubMed ID: 30554801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous remission of proteinuria is a frequent event in phospholipase A2 receptor antibody-negative patients with membranous nephropathy.
    Hoxha E; Harendza S; Pinnschmidt HO; Tomas NM; Helmchen U; Panzer U; Stahl RA
    Nephrol Dial Transplant; 2015 Nov; 30(11):1862-9. PubMed ID: 26142398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.